NeurogesX’s Qutenza Potential For Successful Committee Review Hinges On Post Hoc Efficacy Analyses

FDA looks askance at the sponsor’s post hoc analyses showing efficacy for its pain patch (capsaicin 8%) for HIV-associated neuropathic pain 30 minutes after application.